Markham PD - Search Results

1

Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.

Zhao J, Pinczewski J, Gómez-Román VR, Venzon D, Kalyanaraman VS, Markham PD, Aldrich K, Moake M, Montefiori DC, Lou Y, Pavlakis GN, Robert-Guroff M. Zhao J, et al. Among authors: markham pd. J Virol. 2003 Aug;77(15):8354-65. doi: 10.1128/jvi.77.15.8354-8365.2003. J Virol. 2003. PMID: 12857905 Free PMC article.

2

Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.

Earl PL, Wyatt LS, Montefiori DC, Bilska M, Woodward R, Markham PD, Malley JD, Vogel TU, Allen TM, Watkins DI, Miller N, Moss B. Earl PL, et al. Among authors: markham pd. Virology. 2002 Mar 15;294(2):270-81. doi: 10.1006/viro.2001.1345. Virology. 2002. PMID: 12009868 Free article.

3

Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication.

Peng B, Voltan R, Lim L, Edghill-Smith Y, Phogat S, Dimitrov DS, Arora K, Leno M, Than S, Woodward R, Markham PD, Cranage M, Robert-Guroff M. Peng B, et al. Among authors: markham pd. J Virol. 2002 Jun;76(12):6016-26. doi: 10.1128/jvi.76.12.6016-6026.2002. J Virol. 2002. PMID: 12021334 Free PMC article.

4

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.

Patterson LJ, Malkevitch N, Venzon D, Pinczewski J, Gómez-Román VR, Wang L, Kalyanaraman VS, Markham PD, Robey FA, Robert-Guroff M. Patterson LJ, et al. Among authors: markham pd. J Virol. 2004 Mar;78(5):2212-21. doi: 10.1128/jvi.78.5.2212-2221.2004. J Virol. 2004. PMID: 14963117 Free PMC article.

5

Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.

Pal R, Venzon D, Santra S, Kalyanaraman VS, Montefiori DC, Hocker L, Hudacik L, Rose N, Nacsa J, Edghill-Smith Y, Moniuszko M, Hel Z, Belyakov IM, Berzofsky JA, Parks RW, Markham PD, Letvin NL, Tartaglia J, Franchini G. Pal R, et al. Among authors: markham pd. J Virol. 2006 Apr;80(8):3732-42. doi: 10.1128/JVI.80.8.3732-3742.2006. J Virol. 2006. PMID: 16571790 Free PMC article.

6

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.

Buge SL, Richardson E, Alipanah S, Markham P, Cheng S, Kalyan N, Miller CJ, Lubeck M, Udem S, Eldridge J, Robert-Guroff M. Buge SL, et al. J Virol. 1997 Nov;71(11):8531-41. doi: 10.1128/JVI.71.11.8531-8541.1997. J Virol. 1997. PMID: 9343211 Free PMC article.

7

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

Benson J, Chougnet C, Robert-Guroff M, Montefiori D, Markham P, Shearer G, Gallo RC, Cranage M, Paoletti E, Limbach K, Venzon D, Tartaglia J, Franchini G. Benson J, et al. J Virol. 1998 May;72(5):4170-82. doi: 10.1128/JVI.72.5.4170-4182.1998. J Virol. 1998. PMID: 9557706 Free PMC article.

8

Replication of simian immunodeficiency virus (SIV) in ex vivo lymph nodes as a means to assess susceptibility of macaques in vivo.

Margolis L, Glushakova S, Chougnet C, Shearer G, Markham P, Robert-Guroff M, Benveniste R, Miller CJ, Cranage M, Hirsch V, Franchini G. Margolis L, et al. Virology. 2000 Sep 30;275(2):391-7. doi: 10.1006/viro.2000.0528. Virology. 2000. PMID: 10998338 Free article.

9

Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.

Robert-Guroff M, Aldrich K, Muldoon R, Stern TL, Bansal GP, Matthews TJ, Markham PD, Gallo RC, Franchini G. Robert-Guroff M, et al. Among authors: markham pd. J Virol. 1992 Jun;66(6):3602-8. doi: 10.1128/JVI.66.6.3602-3608.1992. J Virol. 1992. PMID: 1374810 Free PMC article.

10

Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus.

Robert-Guroff M, Kaur H, Patterson LJ, Leno M, Conley AJ, McKenna PM, Markham PD, Richardson E, Aldrich K, Arora K, Murty L, Carter L, Zolla-Pazner S, Sinangil F. Robert-Guroff M, et al. Among authors: markham pd. J Virol. 1998 Dec;72(12):10275-80. doi: 10.1128/JVI.72.12.10275-10280.1998. J Virol. 1998. PMID: 9811775 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page